🚀 VC round data is live in beta, check it out!
Fever-Tree Valuation Multiples
Discover revenue and EBITDA valuation multiples for Fever-Tree and similar public comparables like Bega Cheese, Grupo Herdez, Podravka, Princes Group and more.
Fever-Tree Overview
About Fever-Tree
Fevertree Drinks PLC is a UK based holding and investment company. The company is engaged in the business activity of developing and marketing premium mixer drinks. Its product portfolio includes Indian tonic water, Mediterranean tonic water, Elderflower tonic water, Aromatic tonic water, Clementine tonic water, Lemon tonic water, Ginger beer, Ginger ale, Smoky ginger ale, Spiced orange ginger ale, Madagascan cola, Sicilian lemonade, Lemonade, Premium Soda Water and Mediterranean Orange. The company operates in the UK, USA, Europe, and other countries, of which majority of the revenue is from the United Kingdom.
Founded
2013
HQ
Employees
380
Website
Sectors
Financials (LTM)
EV
$1B
Fever-Tree Financials
Fever-Tree reported last 12-month revenue of $511M and EBITDA of $60M.
In the same LTM period, Fever-Tree generated $199M in gross profit, $60M in EBITDA, and $40M in net income.
Revenue (LTM)
Fever-Tree P&L
In the most recent fiscal year, Fever-Tree reported revenue of $498M and EBITDA of $62M.
Fever-Tree expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $511M | XXX | $498M | XXX | XXX | XXX |
| Gross Profit | $199M | XXX | $187M | XXX | XXX | XXX |
| Gross Margin | 39% | XXX | 38% | XXX | XXX | XXX |
| EBITDA | $60M | XXX | $62M | XXX | XXX | XXX |
| EBITDA Margin | 12% | XXX | 12% | XXX | XXX | XXX |
| EBIT Margin | 9% | XXX | 9% | XXX | XXX | XXX |
| Net Profit | $40M | XXX | $33M | XXX | XXX | XXX |
| Net Margin | 8% | XXX | 7% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Fever-Tree Stock Performance
Fever-Tree has current market cap of $1B, and enterprise value of $1B.
Market Cap Evolution
Fever-Tree's stock price is $11.24.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1B | $1B | 0.0% | XXX | XXX | XXX | $0.29 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialFever-Tree Valuation Multiples
Fever-Tree trades at 2.3x EV/Revenue multiple, and 19.6x EV/EBITDA.
EV / Revenue (LTM)
Fever-Tree Financial Valuation Multiples
As of April 20, 2026, Fever-Tree has market cap of $1B and EV of $1B.
Equity research analysts estimate Fever-Tree's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Fever-Tree has a P/E ratio of 32.2x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1B | XXX | $1B | XXX | XXX | XXX |
| EV (current) | $1B | XXX | $1B | XXX | XXX | XXX |
| EV/Revenue | 2.3x | XXX | 2.4x | XXX | XXX | XXX |
| EV/EBITDA | 19.6x | XXX | 19.0x | XXX | XXX | XXX |
| EV/EBIT | 26.5x | XXX | 26.5x | XXX | XXX | XXX |
| EV/Gross Profit | 5.9x | XXX | 6.3x | XXX | XXX | XXX |
| P/E | 32.2x | XXX | 39.2x | XXX | XXX | XXX |
| EV/FCF | 26.7x | XXX | 15.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Fever-Tree Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Fever-Tree Margins & Growth Rates
Fever-Tree's revenue in the last 12 month grew by 7%.
Fever-Tree's revenue per employee in the last FY averaged $1.3M, while opex per employee averaged $0.4M for the same period.
Fever-Tree's rule of 40 is 19% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Fever-Tree's rule of X is 28% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Fever-Tree Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 7% | XXX | 1% | XXX | XXX | XXX |
| EBITDA Margin | 12% | XXX | 12% | XXX | XXX | XXX |
| EBITDA Growth | 24% | XXX | (9%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 19% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 28% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $1.3M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.4M | XXX | XXX | XXX |
| G&A Expenses to Revenue | 12% | XXX | 29% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 29% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Fever-Tree Public Comps
See public comps and valuation multiples for other Food & Beverages comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Fever-Tree | XXX | XXX | XXX | XXX | XXX | XXX |
| Bega Cheese | XXX | XXX | XXX | XXX | XXX | XXX |
| Grupo Herdez | XXX | XXX | XXX | XXX | XXX | XXX |
| Podravka | XXX | XXX | XXX | XXX | XXX | XXX |
| Princes Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Treehouse Foods | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Fever-Tree M&A Activity
Fever-Tree acquired XXX companies to date.
Last acquisition by Fever-Tree was on XXXXXXXX, XXXXX. Fever-Tree acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Fever-Tree
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialFever-Tree Investment Activity
Fever-Tree invested in XXX companies to date.
Fever-Tree made its latest investment on XXXXXXXX, XXXXX. Fever-Tree invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Fever-Tree
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Fever-Tree
| When was Fever-Tree founded? | Fever-Tree was founded in 2013. |
| Where is Fever-Tree headquartered? | Fever-Tree is headquartered in United Kingdom. |
| How many employees does Fever-Tree have? | As of today, Fever-Tree has over 380 employees. |
| Who is the CEO of Fever-Tree? | Fever-Tree's CEO is Timothy Daniel Gray Warrillow. |
| Is Fever-Tree publicly listed? | Yes, Fever-Tree is a public company listed on London Stock Exchange. |
| What is the stock symbol of Fever-Tree? | Fever-Tree trades under FEVR ticker. |
| When did Fever-Tree go public? | Fever-Tree went public in 2014. |
| Who are competitors of Fever-Tree? | Fever-Tree main competitors are Bega Cheese, Grupo Herdez, Podravka, Princes Group. |
| What is the current market cap of Fever-Tree? | Fever-Tree's current market cap is $1B. |
| What is the current revenue of Fever-Tree? | Fever-Tree's last 12 months revenue is $511M. |
| What is the current revenue growth of Fever-Tree? | Fever-Tree revenue growth (NTM/LTM) is 7%. |
| What is the current EV/Revenue multiple of Fever-Tree? | Current revenue multiple of Fever-Tree is 2.3x. |
| Is Fever-Tree profitable? | Yes, Fever-Tree is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Fever-Tree? | Fever-Tree's last 12 months EBITDA is $60M. |
| What is Fever-Tree's EBITDA margin? | Fever-Tree's last 12 months EBITDA margin is 12%. |
| What is the current EV/EBITDA multiple of Fever-Tree? | Current EBITDA multiple of Fever-Tree is 19.6x. |
| What is the current FCF of Fever-Tree? | Fever-Tree's last 12 months FCF is $44M. |
| What is Fever-Tree's FCF margin? | Fever-Tree's last 12 months FCF margin is 9%. |
| What is the current EV/FCF multiple of Fever-Tree? | Current FCF multiple of Fever-Tree is 26.7x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.